US ‘notorious markets’ report warns of risks from online pharmacies
U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says ...
Why We Need to Remember the Physical Effects of Polio
Kennedy Jr.’s lawyer, Aaron Siri, petitioned the U.S. Food and Drug Administration to revoke approval of the polio vaccine.
1,300 pounds of cat food recalled due to salmonella contamination
More than 1,000 pounds of cat food has been recalled due to salmonella contamination. The U.S. Food and Drug Administration ( ...
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
This Illness Is Surging Right Now, And The Signs In Kids Aren't As Easy To Spot
But that’s not always how serious illness plays out. Children who need to be on ventilators, have tracheostomies or ...
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
STAT15h
Leaving FDA, Califf is unapologetic — and warns of staff departures
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...
Johnson & Johnson Gets FDA Priority Review of Nipocalimab in Generalized Myasthenia Gravis
Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.
STAT4h
FDA pushes makers of AI devices to disclose more details on testing, performance
The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...
Zentalis Gets FDA Fast-Track Designation for Azenosertib
Zentalis Pharmaceuticals has won a U.S. Food and Drug Administration fast-track designation for its lead product candidate azenosertib for certain cancer patients with high levels of the Cyclin E1 ...